n-methyl-3,4-methylenedioxyamphetamine has been researched along with methylone in 23 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (8.70) | 29.6817 |
| 2010's | 17 (73.91) | 24.3611 |
| 2020's | 4 (17.39) | 2.80 |
| Authors | Studies |
|---|---|
| Baumann, MH; Del Bello, F; Glennon, RA; Partilla, JS; Sakloth, F | 1 |
| Bossong, MG; Niesink, RJ; Van Dijk, JP | 1 |
| Ishii, H; Nakagawa, Y; Ogata, A; Suzuki, T; Tayama, S | 1 |
| Karila, L; Reynaud, M | 1 |
| Aaron, C; Freeman, S; Hedge, M; Leonard, K; Warrick, BJ; Wilson, J | 1 |
| Ayestas, MA; Baumann, MH; Brandt, SD; Cozzi, NV; Daley, PF; Partilla, JS; Rothman, RB; Ruoho, AE; Shulgin, AT; Sink, JR | 1 |
| Kereszty, EM; Kovács, K; Tóth, AR | 1 |
| Driver, CR; Hoffman, RS; Jakubowski, A; Karpati, A; Kass, D; Kunins, HV; Nelson, LS; Nolan, ML; Paone, D; Ridpath, A | 1 |
| Creehan, KM; Taffe, MA; Vandewater, SA | 2 |
| Aarde, SM; Creehan, KM; Miller, ML; Taffe, MA; Vandewater, SA | 1 |
| Cleland, CM; Palamar, JJ; Salomone, A; Vincenti, M | 1 |
| Kiyatkin, EA; Ren, SE | 1 |
| Aarde, SM; Taffe, MA | 1 |
| Janowsky, A; Miner, NB; O'Callaghan, JP; Phillips, TJ | 1 |
| Di Corcia, D; Gerace, E; Palamar, JJ; Salomone, A; Vincenti, M | 1 |
| Chen, Z; Dolan, SB; Gatch, MB; Huang, R | 1 |
| Beck, A; Flockerzi, V; Maurer, HH; Meyer, MR; Richter, LHJ | 1 |
| Baumann, MH; Blough, BE; Hoener, MC; Kolaczynska, KE; Liechti, ME; Luethi, D; Rice, KC; Suzuki, M; Walter, M | 1 |
| Gore, S; Huber, R; Sprague, JE; van Staaden, MJ | 1 |
| Bergman, J; de Moura, FB; Kohut, SJ; Paronis, CA; Prisinzano, TE; Sherwood, A | 1 |
| Bergman, J; Kohut, SJ; Paronis, CA; Prisinzano, TE; Sherwood, AM; Wakeford, AGP | 1 |
| Bailey, JM; Bowman, SK; Cerveny, SE; Huang, S; Jones, RA; Manke, HN; Nelson, KH; Rice, KC; Riley, AL | 1 |
2 review(s) available for n-methyl-3,4-methylenedioxyamphetamine and methylone
| Article | Year |
|---|---|
GHB and synthetic cathinones: clinical effects and potential consequences.
Topics: Alkaloids; Animals; Designer Drugs; Humans; Illicit Drugs; Indans; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Sodium Oxybate; Substance-Related Disorders | 2011 |
Predicting the Abuse Liability of Entactogen-Class, New and Emerging Psychoactive Substances via Preclinical Models of Drug Self-administration.
Topics: Animals; Behavior, Animal; Methamphetamine; Models, Animal; N-Methyl-3,4-methylenedioxyamphetamine; Psychotropic Drugs; Rats; Self Administration; Substance-Related Disorders | 2017 |
21 other study(ies) available for n-methyl-3,4-methylenedioxyamphetamine and methylone
| Article | Year |
|---|---|
Ethylenedioxy homologs of N-methyl-(3,4-methylenedioxyphenyl)-2-aminopropane (MDMA) and its corresponding cathinone analog methylenedioxymethcathinone: Interactions with transporters for serotonin, dopamine, and norepinephrine.
Topics: Alkaloids; Dopamine; Dopamine Plasma Membrane Transport Proteins; Molecular Structure; N-Methyl-3,4-methylenedioxyamphetamine; Norepinephrine; Norepinephrine Plasma Membrane Transport Proteins; Serotonin; Serotonin Plasma Membrane Transport Proteins | 2015 |
Methylone and mCPP, two new drugs of abuse?
Topics: Adrenergic Uptake Inhibitors; Biogenic Monoamines; Cross-Sectional Studies; Designer Drugs; Humans; Illicit Drugs; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Netherlands; Piperazines; Receptors, Serotonin; Serotonin Receptor Agonists; Substance-Related Disorders | 2005 |
Cytotoxic effects of 3,4-methylenedioxy-N-alkylamphetamines, MDMA and its analogues, on isolated rat hepatocytes.
Topics: 3,4-Methylenedioxyamphetamine; Adenosine Triphosphate; Animals; Cell Death; DNA Damage; Hallucinogens; Hepatocytes; Male; Methamphetamine; Mitochondria, Liver; N-Methyl-3,4-methylenedioxyamphetamine; Oxidative Phosphorylation; Rats; Rats, Inbred F344; Time Factors | 2009 |
Lethal serotonin syndrome after methylone and butylone ingestion.
Topics: 3,4-Methylenedioxyamphetamine; Adult; Fatal Outcome; Female; Humans; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Serotonin Syndrome; Young Adult | 2012 |
The designer methcathinone analogs, mephedrone and methylone, are substrates for monoamine transporters in brain tissue.
Topics: 1-Methyl-4-phenylpyridinium; Analysis of Variance; Animals; Chromatography, High Pressure Liquid; Dopamine; Dopamine Plasma Membrane Transport Proteins; Dose-Response Relationship, Drug; Electrochemistry; Hallucinogens; In Vitro Techniques; Locomotion; Male; Membrane Transport Proteins; Methamphetamine; Microdialysis; N-Methyl-3,4-methylenedioxyamphetamine; Norepinephrine Plasma Membrane Transport Proteins; Nucleus Accumbens; Rats; Rats, Sprague-Dawley; Serotonin; Synaptosomes; Time Factors; Tritium | 2012 |
[A new designer drug: methylone related death].
Topics: Adolescent; Amphetamine; Asthma; Autopsy; Causality; Death, Sudden, Cardiac; Designer Drugs; Drug Overdose; Fatal Outcome; Fatty Liver; Heart Defects, Congenital; Humans; Hungary; Male; Methamphetamine; Muscle, Smooth; N-Methyl-3,4-methylenedioxyamphetamine | 2012 |
Illnesses and deaths among persons attending an electronic dance-music festival - New York City, 2013.
Topics: Adolescent; Adult; Alcohol Drinking; Cocaine; Dancing; Emergency Service, Hospital; Female; Holidays; Humans; Illicit Drugs; Male; Methamphetamine; Music; N-Methyl-3,4-methylenedioxyamphetamine; New York City; Substance-Related Disorders; Young Adult | 2014 |
Intravenous self-administration of mephedrone, methylone and MDMA in female rats.
Topics: Administration, Intravenous; Animals; Central Nervous System Stimulants; Conditioning, Operant; Discrimination, Psychological; Dose-Response Relationship, Drug; Female; Hallucinogens; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Rats; Rats, Wistar; Reinforcement Schedule; Self Administration; Time Factors | 2015 |
One day access to a running wheel reduces self-administration of D-methamphetamine, MDMA and methylone.
Topics: Animals; Central Nervous System Stimulants; Drug-Seeking Behavior; Female; Male; Methamphetamine; Motor Activity; N-Methyl-3,4-methylenedioxyamphetamine; Rats; Self Administration | 2015 |
Intravenous self-administration of entactogen-class stimulants in male rats.
Topics: Administration, Intravenous; Amphetamine-Related Disorders; Animals; Catheters, Indwelling; Central Nervous System Stimulants; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Male; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Rats, Wistar; Self Administration; Sex Characteristics | 2015 |
Detection of "bath salts" and other novel psychoactive substances in hair samples of ecstasy/MDMA/"Molly" users.
Topics: Adolescent; Adult; Alkaloids; Animals; Drug Users; Female; Hair; Humans; Illicit Drugs; Male; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; New York City; Self Report; Substance-Related Disorders; Surveys and Questionnaires; Tandem Mass Spectrometry; Young Adult | 2016 |
MDMA, Methylone, and MDPV: Drug-Induced Brain Hyperthermia and Its Modulation by Activity State and Environment.
Topics: Animals; Antipsychotic Agents; Benzodioxoles; Body Temperature; Brain; Carbazoles; Carvedilol; Central Nervous System Stimulants; Clozapine; Environment; Fever; Humans; Interpersonal Relations; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Propanolamines; Pyrrolidines; Rats; Social Behavior; Synthetic Cathinone; Vasoconstriction; Vasodilator Agents | 2017 |
The combined effects of 3,4-methylenedioxymethamphetamine (MDMA) and selected substituted methcathinones on measures of neurotoxicity.
Topics: Animals; Benzodioxoles; Body Temperature Regulation; Corpus Striatum; Dopamine; Glial Fibrillary Acidic Protein; Gliosis; Male; Methamphetamine; Mice; N-Methyl-3,4-methylenedioxyamphetamine; Pyrrolidines; Synthetic Cathinone; Tyrosine 3-Monooxygenase | 2017 |
Hair Testing for Drugs of Abuse and New Psychoactive Substances in a High-Risk Population.
Topics: Cyclohexanones; Cyclohexylamines; Hair; Humans; Illicit Drugs; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Pentanones; Prevalence; Psychotropic Drugs; Pyrrolidines; Substance Abuse Detection; Substance-Related Disorders | 2017 |
"Ecstasy" to addiction: Mechanisms and reinforcing effects of three synthetic cathinone analogs of MDMA.
Topics: Animals; Benzazepines; Central Nervous System Stimulants; Conditioning, Operant; Disease Models, Animal; Dopamine Antagonists; Dopamine Plasma Membrane Transport Proteins; Drug Combinations; Hallucinogens; HEK293 Cells; Humans; Male; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Patch-Clamp Techniques; Rats; Rats, Sprague-Dawley; Reinforcement, Psychology; Self Administration; Serotonin; Substance-Related Disorders | 2018 |
Cytotoxicity of new psychoactive substances and other drugs of abuse studied in human HepG2 cells using an adopted high content screening assay.
Topics: Acetaminophen; Alkaloids; Biological Assay; Chromatography, Liquid; Fluorescent Dyes; Fluvastatin; Hep G2 Cells; Hepatocytes; Humans; Illicit Drugs; Indans; Indoles; Membrane Potential, Mitochondrial; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Propranolol; Quinolines; Simvastatin; Tandem Mass Spectrometry; Toxicity Tests | 2019 |
Metabolites of the ring-substituted stimulants MDMA, methylone and MDPV differentially affect human monoaminergic systems.
Topics: Benzodioxoles; Central Nervous System Stimulants; Dopamine; HEK293 Cells; Humans; Membrane Transport Proteins; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Norepinephrine; Pyrrolidines; Serotonin; Synthetic Cathinone | 2019 |
Synthetic cathinones and their phenethylamine analogues produce distinct psychomotor and reward behavior in crayfish.
Topics: Alkaloids; Amphetamines; Animals; Astacoidea; Behavior, Animal; Central Nervous System Sensitization; Central Nervous System Stimulants; Conditioning, Psychological; Male; Methamphetamine; Motor Activity; N-Methyl-3,4-methylenedioxyamphetamine; Phenethylamines; Reward | 2020 |
Reinforcing effects of synthetic cathinones in rhesus monkeys: Dose-response and behavioral economic analyses.
Topics: Alkaloids; Animals; Behavior, Animal; Benzodioxoles; Central Nervous System Stimulants; Cocaine; Dopamine Plasma Membrane Transport Proteins; Dose-Response Relationship, Drug; Female; Macaca mulatta; Male; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Pentanones; Protein Binding; Pyrrolidines; Reinforcement, Psychology; Self Administration; Serotonin Plasma Membrane Transport Proteins; Synthetic Cathinone; Synthetic Drugs | 2021 |
Discriminative-Stimulus Effects of Synthetic Cathinones in Squirrel Monkeys.
Topics: Alkaloids; Animals; Behavior, Animal; Benzodioxoles; Central Nervous System Stimulants; Discrimination Learning; Interoception; Male; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Propiophenones; Psychotropic Drugs; Pyrrolidines; Saimiri; Synthetic Cathinone | 2021 |
Methylone pre-exposure differentially impacts the aversive effects of MDPV and MDMA in male and female Sprague-Dawley rats: Implications for abuse vulnerability.
Topics: Animals; Benzodioxoles; Central Nervous System Stimulants; Dose-Response Relationship, Drug; Female; Male; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Pyrrolidines; Rats; Rats, Sprague-Dawley; Substance-Related Disorders | 2022 |